Freiberg; Christoph
Patent Applications and Registrations
Patent applications and USPTO patent grants for Freiberg; Christoph.The latest application filed is for "anti-ceacam6 antibodies and uses thereof".
- Freiberg; Christoph - Wuppertal DE
| Patent | Date |
|---|---|
| Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof Grant 11,077,187 - Zhao , et al. August 3, 2 | 2021-08-03 |
| Anti-ceacam6 Antibodies And Uses Thereof App 20200181261 - WILLUDA; Jorg ; et al. | 2020-06-11 |
| Anti-ceacam6 Antibodies And Uses Thereof App 20200157214 - WILLUDA; Jorg ; et al. | 2020-05-21 |
| Anti-CEACAM6 antibodies and uses thereof Grant 10,584,167 - Willuda , et al. | 2020-03-10 |
| Epitope Of Optimized Humanized Monoclonal Antibodies Against Activated Protein C And Uses Thereof App 20180326053 - ZHAO; Xiao-Yan ; et al. | 2018-11-15 |
| Anti-ceacam6 Antibodies And Uses Thereof App 20180162940 - WILLUDA; Jorg ; et al. | 2018-06-14 |
| Neutralizing prolactin receptor antibody Mat3 and its therapeutic use Grant 9,777,063 - Freiberg , et al. October 3, 2 | 2017-10-03 |
| Neutralizing prolactin receptor antibodies and their therapeutic use Grant 9,649,374 - Otto , et al. May 16, 2 | 2017-05-16 |
| Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use App 20160319029 - FREIBERG; Christoph ; et al. | 2016-11-03 |
| Anti-tweakr Antibodies And Uses Thereof App 20160237160 - VOTSMEIER; Christian ; et al. | 2016-08-18 |
| Relaxin fusion polypeptides and uses thereof Grant 9,382,305 - Wilmen , et al. July 5, 2 | 2016-07-05 |
| Neutralizing prolactin receptor antibody Mat3 and its therapeutic use Grant 9,353,186 - Freiberg , et al. May 31, 2 | 2016-05-31 |
| Neutralizing prolactin receptor antibodies and their therapeutic use Grant 9,241,989 - Otto , et al. January 26, 2 | 2016-01-26 |
| Relaxin Fusion Polypeptides And Uses Thereof App 20140187491 - Wilmen; Andreas ; et al. | 2014-07-03 |
| Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use App 20140141003 - Freiberg; Christoph ; et al. | 2014-05-22 |
| Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130272968 - Otto; Christiane ; et al. | 2013-10-17 |
| Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130171147 - Otto; Christiane ; et al. | 2013-07-04 |
| Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130129739 - Ottto; Christiane ; et al. | 2013-05-23 |
| Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130022606 - Otto; Christiane ; et al. | 2013-01-24 |
| Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20120321632 - Otto; Christiane ; et al. | 2012-12-20 |
| Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20120315276 - Otto; Christiane ; et al. | 2012-12-13 |
| Cinnamic acid amides App 20090149528 - Brunner; Nina ; et al. | 2009-06-11 |
| Derivatives of andrimide and moiramide B having antibacterial properties Grant 7,544,709 - Brunner , et al. June 9, 2 | 2009-06-09 |
| Antibacterial amide macrocycles IV Grant 7,446,102 - Endermann , et al. November 4, 2 | 2008-11-04 |
| Cinnamic acid amides Grant 7,402,683 - Brunner , et al. July 22, 2 | 2008-07-22 |
| Antibacterial Amide Macrocycles Iv App 20080076745 - Endermann; Rainer ; et al. | 2008-03-27 |
| Arylamides Grant 7,348,357 - Brunner , et al. March 25, 2 | 2008-03-25 |
| Cinnamic acid amides App 20060178369 - Brunner; Nina ; et al. | 2006-08-10 |
| Arylamides App 20060173040 - Brunner; Nina ; et al. | 2006-08-03 |
| Derivatives of andrimide and moiramide b having antibacterial properties App 20050080129 - Brunner, Nina ; et al. | 2005-04-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 